Gerald A. Faich

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

32h-index6.8kcitations105works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacovigilance and Adverse Drug Reactions(28), Pharmaceutical studies and practices(17), Pharmaceutical industry and healthcare(12), Schizophrenia research and treatment(9), Pharmaceutical Economics and Policy(9)

Publications105 total

Evaluation of First Year Experience of a State Pilot Project to Promote Physician Reporting of Adverse Drug Events to the Food and Drug Administration
Pharmacoepidemiology·2018Open Access
Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database
Current Medical Research and Opinion·2015· 38 cited
Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia
Contemporary Clinical Trials·2012· 9 cited
Cardiac Event Rates in Patients with Newly Diagnosed and Relapsed Multiple Myeloma in US Clinical Practice.
Blood·2012· 46 cited
Adverse Reaction Signaling and Disproportionality Analysis: An Update
Drug Information Journal·2012· 10 cited
Mo1700 Incidence of Selected Adverse Events Among Patients With Inflammatory Bowel Disease (IBD) in the Healthcore Integrated Research Database (Hird [SM])
Gastroenterology·2012
Mo1703 Incidence of Selected Adverse Events (AES) in Inflammatory Bowel Disease (IBD) Patients With and Without Exposure to Anti-Tumor Necrosis Factor Alpha (Anti-TNFa) Therapy
Gastroenterology·2012
Comment on FDA's quality assessment of ADE reports from an electronic health record project
Pharmacoepidemiology and Drug Safety·2012
Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial
Open Journal of Psychiatry·2012Open Access
Review of Drug Safety Data: How to Analyze, Summarize, and Interpret to Determine Risk
Drug Information Journal·2011
Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
American Journal of Psychiatry·2010· 120 cited
THE ZIPRASIDONE OBSERVATIONAL STUDY OF CARDIAC OUTCOMES (ZODIAC): FINDINGS FROM A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN REAL-WORLD USE AMONG 18154 PATIENTS WITH SCHIZOPHRENIA
Schizophrenia Research·2010· 2 cited
PRIMARY AND READJUDICATION MORTALITY RESULTS FROM ZODIAC, A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA
Schizophrenia Research·2010· 5 cited
Cardiac safety of diabetes therapies and postmarketing requirements
Pharmacoepidemiology and Drug Safety·2008· 2 cited
Comparative mortality associated with ziprasidone vs. olanzapine in real-world use: The ziprasidone observational study of cardiac outcomes (zodiac)
European Psychiatry·2008· 5 cited
310 – Comparative mortality associated with ziprasidone vs. olanzapine in real-world use: The ziprasidone observational study of cardiac outcomes (zodiac)
Schizophrenia Research·2008· 11 cited
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
The Journal of Clinical Psychiatry·2008· 35 cited
Cardiac Arrhythmia Assessment in Phase IV Clinical Studies
Humana Press eBooks·2007· 2 cited
Cardiac risk factors and schizophrenia: An analysis of 18,094 patients enrolled in an international comparative trial of olanzapine and ziprasidone
European Psychiatry·2007· 2 cited
Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation
Drug Safety·2007· 75 cited
page 1 of 6Next →

Frequent Co-authors

Robert Makuch(4), William B. White(3), Susan E. Ellis(3), Carlene Baum(3), Joel N. Kuritsky(3), Andrew Whelton(2), J B Lefkowith(2), Kenneth M. Verburg(2), Gilbert Geis(2), Howard Fishbein(2), Harold I. Feldman(2), Marshall M. Joffe(2), Wensheng Guo(2), Jeffrey Borer(2), Sybil M. Eng(2), Robert F. Reynolds(2), Jeremy N. Ruskin(2), John M. Kane(2), B-E. Wiholm(2), Janet B. Arrowsmith(2)